Genomic Data Collection Encouraged, But Not Mandated, For Early Clinical Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA draft guidance emphasizes importance of pre-specifying DNA sample collection at the start of a clinical program.